Bachem Holding AG

Bachem Holding AG

0QND · London Exchange

Bachem Holding AG (0QND) is a Medical pharmaceuticals company in the Healthcare sector, listed on London Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Bachem Holding AG in 2026. The next earnings report is expected on March 4, 2027.

Earnings calendar

Next earnings date

04 Mar 2027

In 195 days

EPS estimate

2.43

Revenue estimate

781.2M

Past earnings

30 Jul 2026
EPS actual
0.82 (+2.4%)
estimate 0.80
Revenue actual
401.2M (-1.2%)
estimate 406.1M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 Mar 2026
EPS actual
—
estimate 1.11
Revenue actual
475.9M (+1.9%)
estimate 466.9M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
24 Jul 2025
EPS actual
0.84 (+31.4%)
estimate 0.64
Revenue actual
394.5M (+17.2%)
estimate 336.6M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Bachem Holding AG beat consensus on EPS but missed revenue expectations, with EPS of USD 0.8234 coming in 2.4% above the USD 0.8041 estimate and revenue of USD 401.18 million falling 1.2% short of the USD 406.14 million forecast. In the prior quarter, revenue came in ahead of expectations.

Dividend calendar

Next ex-dividend

—

Not scheduled

Next payment

—

Not scheduled

Dividend amount

—

Not available

Past dividends

Ex-dividend Payment Amount
04 May 2026 06 May 2026 1.15

EPS (Earnings Per Share)

Revenue

Dividend per share

Company profile

Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.

Sector
Healthcare
Industry
Medical pharmaceuticals
Country
Switzerland
Exchange
London Exchange
CEO
Peter Grogg
Employees
2,207
IPO date
03 Dec 2015
ISIN
CH1176493729
Website
bachem.com

Frequently asked questions

When does Bachem Holding AG (0QND) next report earnings?

Bachem Holding AG (0QND) is scheduled to report earnings on March 4, 2027.

What was Bachem Holding AG's most recent earnings date?

Bachem Holding AG (0QND) last reported earnings on July 30, 2026.

Where is Bachem Holding AG stock listed?

Bachem Holding AG (0QND) is listed on London Exchange.